12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Molecular Partners (NASDAQ:MOLN) stock rose 39.1% to $11.07 during Thursday’s regular session. The market value of their…
Analyst Scoreboard: 4 Ratings For VYNE Therapeutics
Across the recent three months, 4 analysts have shared their insights on VYNE Therapeutics (NASDAQ:VYNE), expressing a variety…
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Monogram Orthopaedics (NASDAQ:MGRM) stock increased by 19.1% to $2.31 during Monday’s pre-market session. The company’s market cap…
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Qilian Intl Hldg Gr (NASDAQ:QLI) shares rose 63.8% to $1.04 during Friday’s after-market session. The market value…
Top 4 Health Care Stocks That May Rocket Higher In Q1
The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Shares of Richardson Electronics, Ltd. (NASDAQ: RELL) fell sharply in today’s pre-market trading after the company posted weaker-than-expected results for its second quarter.
Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 500 points on Monday.
The Dow traded up 1.67% to 32,959.68 while the NASDAQ rose 1.25% to 12,800.95. The S&P 500 also rose, gaining, 1.23% to 4,167.91.
Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Gainers
Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United Therapeutics agreed to acquire the company for $3.25 per share in cash.
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Miromatrix Medical (NASDAQ:MIRO) shares increased by 217.2% to $3.3 during Monday’s regular session. The current volume of…
Positive Momentum For VYNE Therapeutics’ Psoriasis, Rheumatoid Arthritis Candidate – Analyst Expresses Encouragement
Earlier today, VYNE Therapeutics Inc (NASDAQ: VYNE) released new preclinical data showing the positive effect of its VYN202 in preclinical models of